Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A)

Cancer Prevention Research

Volumn 5, Issue 1, 2012, Pages 73-81

  Hemachandra, L P Madhubhani P ^a   Chandrasena, R Esala P ^a   Chen, Shao Nong ^a   Main, Matthew ^a   Lankin, David C ^a   Scism, Robert A ^a   Dietz, Birgit M ^a   Pauli, Guido F ^a   Thatcher, Gregory R J ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARINGENIN; CARCINOGEN; CYTOCHROME P450; ESTRADIOL; ESTROGEN; QUINONE DERIVATIVE; XANTHOHUMOL;

ARTICLE; BREAST EPITHELIUM; CANCER CHEMOTHERAPY; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; ESTROGEN METABOLISM; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMULUS LUPULUS; HYDROXYLATION; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, LIQUID; CIMICIFUGA; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; HUMULUS; MASS SPECTROMETRY; MODELS, CHEMICAL; OXIDATIVE STRESS; PLANT EXTRACTS; RECEPTORS, ESTROGEN;

EID: 84862943050     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0348     Document Type: Article

References (50)

1. Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003;87:1-25. (Pubitemid 37421335)
2. Yaghjyan L, Colditz G. Estrogens in the breast tissue: a systematic review. Cancer Cause Control 2011;22:529-40.
3. Cavalieri EL, Rogan EG. Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol 2010;6:75-91.
4. Bolton JL. Mechanisms of estrogen carcinogenesis: modulation by botanical natural products. In: Penning TM, editor. Chemical carcinogenesis. Philadelphia, PA: Humana Press; 2011. p. 75-93.
5. Bolton JL, Thatcher GRJ. Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 2008;21:93-101. (Pubitemid 351219711)
6. Schiff R, Chamness G, Brown P. Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). Breast Cancer Res 2003;5:228-31. (Pubitemid 37080849)
7. Strasser-Weippl K, Goss PE. Advances in adjuvant hormonal therapy for postmenopausal women. J Clin Oncol 2005;23:1751-9. (Pubitemid 46211427)
8. Goss P. Anti-aromatase agents in the treatment and prevention of breast cancer. Cancer Control 2002;9:2-8. (Pubitemid 34457335)
9. Burnett C, Valentini S, Cabreiro F, Goss M, Somogyvári M, Piper MD, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Eng J Med 2011;364:2381-91.
10. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Catechol-O- methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 2001;61:6716-22. (Pubitemid 32896493)
11. Beuten J, Gelfond JA, Byrne JJ, Balic I, Crandall AC, Johnson-Pais TL, et al. CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis 2008;29:1751-7.
12. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, et al. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 1998;19:291-8. (Pubitemid 28375423)
13. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990;50:6075-86. (Pubitemid 20331424)
14. Park SA, NaHK, Kim EH, Cha YN, Surh YJ. 4-Hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 2009;69:2416-24.
15. Cuendet M, Liu X, Pisha E, Li Y, Yao J, Yu L, et al. Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression. Mutat Res 2004;550:109-21. (Pubitemid 38595666)
16. Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, et al. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004; 25:2005-13. (Pubitemid 39405921)
17. Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res 2008;1:135-45.
18. Rees M. Alternative treatments for the menopause. Best Pract Res Clin Obstet Gynaecol 2009;23:151-61.
19. Dog TL, Marles R, Mahady G, Gardiner P, Ko R, Barnes J, et al. Assessing safety of herbal products for menopausal complaints: An international perspective. Maturitas 2010;66:355-62.
20. Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, et al. Estrogens and congeners from spent hops (Humulus lupulus L.). J Nat Prod 2004;67:2024-32. (Pubitemid 40092549)
21. Overk CR, Guo J, Chadwick LR, Lantvit DD, Minassi A, Appendino G, et al. In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem Biol Interact 2008;176:30-9.
22. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, et al. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem 2005;53:6246-53. (Pubitemid 41169368)
23. Burdette JE, Liu J, ChenSN, Fabricant DS, Piersen CE, Barker EL, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661-70.
24. Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr Cancer Ther 2003;2:120-38. (Pubitemid 37322457)
25. Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, et al. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol Cancer Ther 2002;1:959-69.
26. Dietz BM, Kang YH, Liu G, Eggler AL, Yao P, Chadwick LR, et al. Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol 2005;18:1296-305. (Pubitemid 41170254)
27. Lamy V, Roussi S, Chaabi M, Gossé F, Schall N, Lobstein A, et al. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 2007;28:1575-81. (Pubitemid 47241808)
28. Einbond LS, Su T, Wu HA, Friedman R, Wang X, Jiang B, et al. Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Res 2007;27:697-712. (Pubitemid 46586971)
29. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat 2004;84:151-60. (Pubitemid 38393365)
30. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-66.
31. Xu X, Keefer LK, Ziegler RG, Veenstra TD. A liquid chromatography-mass spectrometry method for the quantitative analysis of urinary endogenous estrogen metabolites. Nat Protocols 2007;2:1350-5. (Pubitemid 46952316)
32. Kastrati I, Edirisinghe PD, Wijewickrama GT, Thatcher GRJ. Estrogen-induced apoptosis of breast epithelial cells Is blocked by NO/cGMP and mediated by extranuclear estrogen receptors. Endocrinology 2010;151:5602-16.
33. Mikstacka R, Przybylska D, Rimando AM, Baer-Dubowska W. Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 2007;51:517-24. (Pubitemid 47083688)
34. Chang M, Peng KW, Kastrati I, Overk CR, Qin ZH, Yao P, et al. Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology 2007;148:4793-802. (Pubitemid 47481516)
35. Rangiah K, Shah SJ, Vachani A, Ciccimaro E, Blair IA. Liquid chromatography/ mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women. Rapid Commun Mass Sp 2011;25:1297-307.
36. Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, et al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci 2009;1155:132-40.
37. Blair IA. Analysis of estrogens in serum and plasma from postmenopausal women: Past present, and future. Steroids 2010;75:297-306.
38. Piwowarska J, Radowicki S, Pachecka J. Simultaneous determination of eight estrogens and their metabolites in serum using liquid chromatography with electrochemical detection. Talanta 2010;81:275-80.
39. Lu F, Zahid M, Saeed M, Cavalieri EL, Rogan EG. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells: The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol 2007;105:150-8. (Pubitemid 47211948)
40. Russo J, Fernandez SV, Russo PA, et al. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 2006;20:1622-34. (Pubitemid 44943799)
41. Zahid M, Gaikwad NW, Ali MF, Lu F, Saeed M, Yang L, et al. Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free Radical Bio Med 2008;45:136-45.
42. Zahid M, Saeed M, Beseler C, Rogan EG, Cavalieri EL. Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells. Free Radical Bio Med 2011;50:78-85.
43. Burdette JE, Chen SN, Lu ZZ, Xu H, White BE, Fabricant DS, et al. Black cohosh (Cimicifuga racemosa L.) protects against menadione-induced DNA damage through scavenging of reactive oxygen species: bioassay-directed isolation and characterization of active principles. J Agric Food Chem 2002;50:7022-8. (Pubitemid 35332778)
44. Aiyer HS, Gupta RC. Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Cancer Prev Res 2010;3:727-37.
45. Tsuchiya Y, Nakajima M, Kyo S, Kanaya T, Inoue M, Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004;64:3119-25. (Pubitemid 38581412)
46. Lee SS, Jeong HG, Yang KH. Effects of estradiol and progesterone on cytochrome P4501A1 expression in Hepa 1c1c7 cells. Biochem Mol Biol Int 1998;45:775-81. (Pubitemid 28393546)
47. Chen JQ, Russo PA, Cooke C, Russo IH, Russo J. ER[beta] shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogeninduced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta 2007;1773:1732-46.
48. Monteiro R, Faria A, Azevedo I, Calhau C. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol 2007;105:124-30. (Pubitemid 47211960)
49. Amer DAM, Kretzschmar G,M€uller N, Stanke N, Lindemann D, Vollmer G. Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line. J Steroid Biochem Mol Biol 2010;120:208-17.
50. Bolca S, Li J, Nikolic D, Roche N, Blondeel P, Possemiers S, et al. Disposition of hop prenylflavonoids in human breast tissue. Mol Nutr Food Res 2010;54:S284-S94.